American Physicians Capital Inc.

Public Company, Headquarters Location
PO Box 1471, East Lansing, MI 48826-1471, United States
(800)748-0465, (517)351-1150, (517)351-5565 fax, http://www.apcapital.com

Primary SIC: Hospital And Medical Service Plans, Primary NAICS: Direct Health and Medical Insurance Carriers
Description: Insurance: Insurance holding company offering hospital and medical service plans primarily for the medical professional.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

American Physicians Capital Inc., News and Information

American Physicians Capital, Inc. Reports Third Quarter 2009 Results and Increases Cash Dividend.
Health & Medicine Week; 11/9/2009; 750 words; American Physicians Capital, Inc. (APCapital) (NASDAQ:ACAP) announced...see also American Physicians Capital, Inc.). The 2009 year-to-date net income...Keywords: American Physicians Capital, Inc., American Physicians ...

Steven R. Goldstein, M.D., Joins Bionovo's Menerba Medical Advisory Board.
PR Newswire; 11/5/2009; 1143 words; ...FirstCall/ -- Bionovo, Inc. announced today...President of the American Institute of Ultrasound...safety. Bionovo, Inc. Bionovo is a pharmaceutical...traded on the NASDAQ Capital Market under the...business of Bionovo, Inc. that can be identified...market acceptance, physician ...

InterMune Falls On Lowered Guidance; Reports Positive Data.
BIOWORLD Today; 11/4/2009; 1052 words; ...Associate Managing Editor InterMune Inc. said late Wednesday that...positive data presented at [the American Thoracic Society] and growing physician awareness about the diagnosis...day, as Bear Stearns, RBC Capital Markets, Adams Harkness...

Orexigen Prices IPO To Raise $84M For Obesity Programs.
BIOWORLD Today; 11/3/2009; 1190 words; ...Chinese firm 3SBio Inc.'s $115.2 million...priced 7.2 million American depositary shares...Insight Pharmaceuticals Inc. (See BioWorld...allotted for working capital, general corporate...products to primary care physicians. Orexigen's principal...IPO; KPCB Holdings Inc., of Menlo ...

ImClone's Phase III Erbitux Trial In NSCLC Fails To Hit Endpoint.
BIOWORLD Today; 11/3/2009; 1360 words; ...Editor ImClone Systems Inc.'s Phase III miss...bevacizumab), Genentech Inc.'s VEGF inhibitor...probably depends more on physicians' opinion regarding...June meeting of the American Society of Clinical...Sendek, of Lazard Capital Markets, maintained...Clinical Intelligence Inc., ...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.